The stock of Cigna Group (NYSE: CI) has decreased by -0.34 when compared to last closing price of 292.46.Despite this, the company has seen a loss of -3.75% in its stock price over the last five trading days. prnewswire.com reported 2025-02-04 that Fifth Ward Elementary School Students Joined in the Safe Zone Event Activities GARYVILLE, La., Feb. 4, 2025 /PRNewswire/ — V incent Country Safe Zone Activity Day Presented by Cigna Healthcare was held today during Super Bowl LIX week at Garyville/Mt.
Is It Worth Investing in Cigna Group (NYSE: CI) Right Now?
The price-to-earnings ratio for Cigna Group (NYSE: CI) is above average at 23.82x. The 36-month beta value for CI is also noteworthy at 0.54. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 7 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for CI is 273.76M, and at present, short sellers hold a 1.52% of that float. The average trading volume of CI on February 05, 2025 was 2.05M shares.
CI’s Market Performance
The stock of Cigna Group (CI) has seen a -3.75% decrease in the past week, with a 6.18% rise in the past month, and a -7.42% fall in the past quarter. The volatility ratio for the week is 4.03%, and the volatility levels for the past 30 days are at 2.61% for CI. The simple moving average for the last 20 days is 0.95% for CI’s stock, with a simple moving average of -11.49% for the last 200 days.
Analysts’ Opinion of CI
Many brokerage firms have already submitted their reports for CI stocks, with Piper Sandler repeating the rating for CI by listing it as a “Overweight.” The predicted price for CI in the upcoming period, according to Piper Sandler is $400 based on the research report published on June 26, 2024 of the previous year 2024.
Robert W. Baird, on the other hand, stated in their research note that they expect to see CI reach a price target of $388. The rating they have provided for CI stocks is “Outperform” according to the report published on May 30th, 2024.
Barclays gave a rating of “Overweight” to CI, setting the target price at $393 in the report published on March 06th of the previous year.
CI Trading at -1.74% from the 50-Day Moving Average
After a stumble in the market that brought CI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.40% of loss for the given period.
Volatility was left at 2.61%, however, over the last 30 days, the volatility rate increased by 4.03%, as shares surge +3.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.62% lower at present.
During the last 5 trading sessions, CI fell by -3.75%, which changed the moving average for the period of 200-days by -15.78% in comparison to the 20-day moving average, which settled at $288.71. In addition, Cigna Group saw 5.55% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CI starting from Triplett Michael W, who proposed sale 2,506 shares at the price of $293.39 back on Feb 03 ’25. After this action, Triplett Michael W now owns shares of Cigna Group, valued at $735,235 using the latest closing price.
DeLaney William J III, the Director of Cigna Group, sale 2,691 shares at $342.68 during a trade that took place back on Aug 19 ’24, which means that DeLaney William J III is holding 17,539 shares at $922,152 based on the most recent closing price.
Stock Fundamentals for CI
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.23 for the gross margin
The net margin for Cigna Group stands at 0.01. The total capital return value is set at 0.08. Equity return is now at value 7.87, with 2.04 for asset returns.
Based on Cigna Group (CI), the company’s capital structure generated 0.44 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 0.78. The interest coverage ratio of the stock is 5.9.
Currently, EBITDA for the company is 9.57 billion with net debt to EBITDA at 2.89. When we switch over and look at the enterprise to sales, we see a ratio of 0.47. The receivables turnover for the company is 8.28for trailing twelve months and the total asset turnover is 1.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.86.
Conclusion
In summary, Cigna Group (CI) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
